Related Experiment Video
Updated: Mar 10, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Nitric oxide donor hybrid compounds as promising anticancer agents
Qin-Ge Ding1, Jie Zang, Shuai Gao
1Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University.
Nitric oxide (NO) has dual roles in cancer. While low concentrations promote tumors, high concentrations of NO exhibit antitumor effects, driving research into NO donor hybrid compounds for cancer therapy.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Nitric oxide (NO) is a crucial signaling molecule involved in cardiovascular regulation, neurotransmission, and immune responses.
- The concentration-dependent effects of NO in cancer are well-documented, with low levels promoting tumor growth and high levels exhibiting antitumor properties.
Purpose of the Study:
- To review the recent advancements in nitric oxide (NO) donor hybrid compounds.
- To highlight their potential as novel antitumor agents.
Main Methods:
- Literature review of recent research on NO donor hybrid compounds.
- Analysis of the development and application of these compounds in cancer research.
Main Results:
- NO donor hybrid compounds are being actively developed as a therapeutic strategy.
- These compounds leverage the antitumor effects of high NO concentrations.
Conclusions:
- NO donor hybrid compounds represent a promising frontier in cancer therapy.
- Further research and development are warranted to optimize their efficacy and clinical application.
More Related Videos
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Targeted Cancer Therapies
There are several types of targeted therapies against...